Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
2003 1
2005 5
2006 3
2007 5
2008 2
2009 1
2011 3
2013 2
2014 6
2015 3
2016 4
2017 3
2018 4
2019 5
2020 5
2021 4
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
[Autoimmune pancreatitis].
Fjordside E, Novovic S, Schmidt PN, Vind I, Hansen EF. Fjordside E, et al. Among authors: vind i. Ugeskr Laeger. 2015 Dec 14;177(51):V04150349. Ugeskr Laeger. 2015. PMID: 26692034 Free article. Review. Danish.
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
Buhl S, Steenholdt C, Brynskov J, Christensen KR, Dorn-Rasmussen M, Thomsen OØ, Bendtzen K, Klausen TW, Dahlerup JF, Thorsgaard N, Jahnsen J, Molazahi A, Pedersen N, Kjeldsen J, Almer S, Dahl EE, Vind I, Cannon AG, Marsal J, Sipponen T, Agnholt JS, Kievit HAL, Aure SL, Martinsen L, Meisner S, Hansen JM, Ainsworth MA. Buhl S, et al. Among authors: vind i. NEJM Evid. 2022 Aug;1(8):EVIDoa2200061. doi: 10.1056/EVIDoa2200061. Epub 2022 Jun 14. NEJM Evid. 2022. PMID: 38319804
Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index.
Lo B, Prosberg MV, Gluud LL, Chan W, Leong RW, van der List E, van der Have M, Sarter H, Gower-Rousseau C, Peyrin-Biroulet L, Vind I, Burisch J. Lo B, et al. Among authors: vind i. Aliment Pharmacol Ther. 2018 Jan;47(1):6-15. doi: 10.1111/apt.14373. Epub 2017 Oct 9. Aliment Pharmacol Ther. 2018. PMID: 28994131 Review.
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study.
Julsgaard M, Baumgart DC, Baunwall SMD, Hansen MM, Grosen A, Bibby BM, Uldbjerg N, Kjeldsen J, Sørensen HG, Larsen L, Wildt S, Weimers P, Haderslev KV, Vind I, Svenningsen L, Brynskov J, Lyhne S, Vestergaard T, Hvas CL, Kelsen J; NOVA Study Group. Julsgaard M, et al. Among authors: vind i. Aliment Pharmacol Ther. 2021 Nov;54(10):1320-1329. doi: 10.1111/apt.16593. Epub 2021 Sep 2. Aliment Pharmacol Ther. 2021. PMID: 34472644
The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020.
Wewer MD, Arp L, Sarikaya M, Felding OK, Vind I, Pedersen G, Mertz-Nielsen A, Kiszka-Kanowitz M, Boysen T, Theede K, Petersen AM, Nordgaard-Lassen I, Bendtsen F, Burisch J. Wewer MD, et al. Among authors: vind i. Crohns Colitis 360. 2022 Nov 3;4(4):otac041. doi: 10.1093/crocol/otac041. eCollection 2022 Oct. Crohns Colitis 360. 2022. PMID: 36778517 Free PMC article.
58 results